KPNA2 and malignant colon neoplasm: CENP-A also strengthens glycolysis in colon cancer by acting as an upstream transcription activator of an oncogene, KPNA2 (Karyopherin α2 subunit), that is known to be involved in metabolic reprogramming in cancer.